2024-11-17 - Analysis Report
## Pfizer Inc. (PFE) Stock Analysis Report

**1. Performance Comparison & Divergence:**

Pfizer Inc. (PFE) is a biopharmaceutical company that discovers, develops, manufactures, and markets biopharmaceutical products.  The provided data shows a cumulative return of -9.76% for PFE, significantly underperforming the S&P 500 (VOO) which had a cumulative return of 123.86%.  The divergence is -133.62%, indicating PFE's substantial underperformance relative to the market benchmark.  The provided alpha and beta analysis shows varying performance against the market over different time periods, with a recent decline in performance and a low beta suggesting decreased market sensitivity.

**2. Recent Price Movement:**

* **Closing Price:** $24.8
* **5-Day Moving Average:** $25.99
* **20-Day Moving Average:** $27.36
* **60-Day Moving Average:** $28.25

The current price is below all three moving averages, suggesting a downward trend.

**3. Technical Indicators & Expected Return:**

* **RSI (16.78):**  Indicates the stock is in oversold territory, suggesting potential for a bounce.
* **PPO (-0.84):**  Negative value suggests bearish momentum.
* **20-Day Relative Divergence (-0.27):** Shows a recent short-term downward trend.

The current price of $24.8, being below the moving averages and with negative PPO, indicates a bearish short-term outlook.  The expected return is 0.0%, suggesting no significant outperformance relative to the S&P 500 is anticipated in the long term (2+ years) based on the provided information.  This is despite the oversold RSI, highlighting the potential conflict between the price action and the long term forecast.

**4. Recent Earnings & Outlook:**

The provided earnings data reveals mixed results. While some quarters exceeded expectations (e.g., 2024-10-29), others significantly missed (e.g., 2024-01-30 and 2023-10-31). The most recent earnings report (2024-10-29) shows EPS of 1.06 exceeding the expected EPS of 0.614. However,  the trend still needs further analysis to assess future outlook and the volatility surrounding the earnings reports should not be disregarded.

**5. Financial Information:**

* **Revenue and Profitability:** Revenue remains strong, but profit margins show fluctuation, with a notable drop in the last two quarters of 2023.  This is a cause for concern and needs further investigation.
* **Capital and Profitability:** Equity is relatively stable, but ROE shows significant volatility, fluctuating between positive and negative values, reflecting the inconsistent profitability.

The financial data highlight significant inconsistency in both profitability and return on equity, indicating volatility in the company's performance and potential underlying issues impacting consistent returns.

**6. News and Recent Issues:**

*(This section requires access to real-time news sources like Shacknews and Finbold.  I cannot provide specific news analysis without accessing current information.)*  To complete this section, a search for recent PFE news (within the last two days) on Shacknews, Finbold, and other reputable financial news sources would be necessary.  This would include reviewing analyst opinions, market outlook summaries, and highlighting any significant performance news releases.

**7. Overall Analysis:**

PFE's recent performance has been significantly weaker than the S&P 500.  While the stock is currently in oversold territory (RSI), the negative PPO, downward trend indicated by moving averages and inconsistent earnings performance suggest caution.  The significant volatility in financial metrics, including ROE and profit margins, raise concerns about future consistent growth.  Further investigation into recent news and analyst opinions is needed to form a complete investment opinion. The 0.0% expected return suggests there is not a strong case to be made for outperformance versus the index without a fundamental shift in performance.

**8. Recommendations:**

Given the data, a cautious approach is warranted.  While the oversold condition (RSI) might suggest a short-term bounce, the broader trend, indicated by technical indicators and financial reports, points towards a bearish outlook.  Thorough due diligence, including reviewing current news and analyst sentiment, is crucial before considering any investment in PFE.  Further analysis is needed to assess the underlying reasons for the inconsistent performance and profitability before forming an informed investment decision.
